event tracking

Parkinson’s Disease

150 results.

February 23, 2024 Cure Parkinson's and Van Andel Institute fund Phase 2 clinical trial of dapansutrile for Parkinson’s

LONDON (Feb. 23, 2024) — Cure Parkinson’s and Van Andel Institute are delighted to announce funding for a Phase 2 clinical trial…

February 15, 2024 How a ‘blockbuster’ treatment for diabetes and obesity might slow or stop Parkinson’s

A “blockbuster” weight loss medication hailed as the “2023 Breakthrough of the Year” by Science also may have game-changing implications for Parkinson’s…

September 29, 2023 2023 Tom Isaacs Award honors Dr. Natasha Fothergill-Misbah

GRAND RAPIDS (Mich.) Sept. 29, 2023 — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr. Natasha Fothergill-Misbah, Research…

September 12, 2023 At the crossroads of community and research

For more than a decade, Matt Cook has worked to empower communities. As the vice president of community relations at Lake Michigan Credit Union…

August 31, 2023 Positivity and Perseverance: Richard Cebelak’s journey with Parkinson’s disease

Parkinson’s disease is a challenging diagnosis. It requires adjustments to day-to-day life and a change in regular habits. But for Richard Cebelak, Parkinson’s would not…

August 28, 2023 Preliminary phase 2 trial results of lixisenatide presented

Copenhagen, Denmark (August 28, 2023) — A one-year, phase 2 clinical trial of Type 2 diabetes drug lixisenatide has reported positive early results, which indicate…

August 24, 2023 Repairing broken brain circuits may offer path to new Parkinson’s treatments

GRAND RAPIDS, Mich. (August 24, 2023) — Van Andel Institute scientists have identified a series of processes that help the brain adapt to damage…

August 1, 2023 Van Andel Institute appoints neurobiologist Dr. Laurent Roybon as associate professor

GRAND RAPIDS, Mich. (August 1, 2023) — Van Andel Institute has appointed Laurent Roybon, Ph.D., as an associate professor in its Department…